Diseases, Conditions, Syndromes
Coronavirus: Which treatments work and which don't?
Donald Trump's brief stay in hospital in early October raised awareness—once again—of the variety of treatments being investigated for COVID-19.
Oct 22, 2020
0
4
News tagged with interferon beta
Diseases, Conditions, Syndromes
European clinical trial starts on possible coronavirus treatments
A European clinical trial involving some 3,200 people has been launched to test four possible experimental treatments against the coronavirus.
Mar 22, 2020
0
311
Neuroscience
Common treatment for multiple sclerosis may prolong life
Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.
Mar 18, 2019
0
438
Immunology
Newfound mechanism may yield ways to counter mistaken immune attack on body
A newfound genetic regulatory mechanism may shape the immune system's ability to fight viral infections, and play a key role in autoimmune diseases that occur when immune cells attack bodily tissues.
Nov 27, 2018
0
112
Cardiology
Signal flare – how heart muscle cells protect themselves from viral invaders
The human heart is particularly vulnerable to viruses. That's because cardiac myocytes, the heart muscle cells that give your heart its ability to "beat," have one major weakness – they don't reproduce themselves to repair ...
Sep 29, 2017
0
36
Medications
Fingolimod in multiple sclerosis: No hint of added benefit in new therapeutic indication
Since its approval in 2011, the multiple sclerosis drug fingolimod (Gilenya) has already undergone three early benefit assessments, all of which were mainly based on the approval study TRANSFORMS. After a new modification ...
Mar 08, 2016
0
9
Medications
Fingolimod in RRMS: Indication of added benefit in certain patients
Pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) reassessed fingolimod (trade name: Gilenya), a drug for the treatment ...
Jul 06, 2015
0
11
Neuroscience
Study implicates new gene in multiple sclerosis disease activity
A new study led by investigators at Brigham and Women's Hospital (BWH) reports the discovery of a genetic variant that is associated with a patient's likelihood of responding to interferon-beta, one of the medications used ...
May 14, 2015
0
93
Medications
Fingolimod in new therapeutic indication: Added benefit not proven
The immunosuppressive drug fingolimod (trade name: Gilenya) was approved for an expanded therapeutic indication in May 2014: It is now also available for adults with highly active relapsing remitting multiple sclerosis (RRMS) ...
Oct 10, 2014
0
0
Neuroscience
New version of old multiple sclerosis drug performs well in clinical trial
Tests of a new long-acting version of one of the oldest multiple sclerosis (MS) drugs on the market show it worked significantly better than placebo in reducing the number of patient relapses and developments of new or active ...
Apr 30, 2014
0
0
